It is the first COVID-19 vaccine patent granted by China, state-owned newspaper People’s Daily reported on Sunday.
The paper cited documents published by China’s National Intellectual Property Administration as saying that the patent was issued on Aug. 11.
Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also in talks with Russia, Brazil and Chile to launch Phase III trials in those countries.
CanSino’s Hong Kong shares rose around 14% in Monday’s morning session. Its Shanghai shares rose by 6.6% as of midday.
Britain encourages at-risk groups to sign up for COVID-19 vaccine trials
Britain on Monday urged elderly people and volunteers from Black and Asian minority groups to sign up to a COVID-19 vaccine trial registry to boost efforts to find a working vaccine against the disease that offers protection against higher-risk groups.
Over 100,000 people have volunteered to take part in vaccine trials, Britain’s business ministry said, but more volunteers are needed to make sure candidate shots work for everyone.
“Protecting those at risk is the only way we will end this pandemic,” said Kate Bingham, chair of the UK Vaccines Taskforce.